mean

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

2 weeks ago

CGTN: Hainan Free Trade Port: A key gateway for China’s high-level opening up

A month before the official launch of China's Hainan Free Trade Port island-wide special customs operations on December 18, CGTN…

1 month ago

Medkart Champions Generic Drug Quality Amid Rising Consumer Concerns

With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is…

2 months ago

Midea XPRESS MASTER Kitchen Revolutionizes Cooking Routines at IFA 2025

BERLIN, Sept. 6, 2025 /PRNewswire/ -- Midea Group, a 2025 Fortune Global 500 company, has unveiled new XPRESS MASTER kitchen technologies.…

3 months ago